A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer
| Image |  |
|---|---|
| Description | scientific article published on 16 January 2018 |
| Author/s |
author: Phillip Knebel Gerd Mikus Markus Büchler Thomas Schmidt |
| Publication date | January 16, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |